Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.
Valeant doesn't plan to offload Salix; heart docs back Califf as commish; Saunders says pricing issues aren't affected by election
Lilly's experimental Alzheimer's drug fails in another trial; two more patients die during trial for Juno's CAR-T therapy; NEJM launches platform in China
The drugstore chain added drug effectiveness reviews and other information from PatientsLikeMe to its website.
Mylan reports third-quarter loss; analysts say drug-pricing restrictions less likely under Trump; the FDA limits citizen petitions
The new TV spot was developed with CNN and Edelman.
Listen Up was the internal communications element Level Brand created to help employees learn how to improve member experience.
Klick Ideas Exchange united leading CEOs and high-level executives of biotech and pharmaceutical companies, thought leaders, and other industry influencers to explore issues that are shaping the future of healthcare.
Pfizer drops plans to split into two companies; Merck's Keytruda gains competitive edge in China; Apple may be developing health software
The consultancy includes Double Helix, which was acquired by McCann in 2012.
Drugmakers to remove incentives for sales reps marketing antibiotics; Mylan CEO defends EpiPen pricing; fitness trackers don't help people lose weight
GSK names new CEO; the FDA approves first Duchenne muscular dystrophy drug; Sanofi files Lantus patent lawsuit against Merck
Retzlaff files a complaint against Turing; Pfizer to buy antibiotics from AstraZeneca; Mylan's marketing for EpiPen faces criticism
Pfizer's commercial expertise in urology and oncology could help propel Medivation's Xtandi to new heights.
Pfizer to acquire cancer drugmaker Medivation; Valeant names new CFO; Apple acquires health data startup
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.
Only one new osteoporosis drug has been approved over the last six years.
PhRMA and BIO, which represent life sciences firms, developed principles about sharing truthful and non-misleading information with payers and providers.
Valeant reorganizes executive team; experimental asthma drug developed by Novartis shows promising results; Teva launches generic Gleevec
The event technology platform plans to integrate a conference note-taking app developed by AstraZeneca and DigitasLBi.
Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info
A story about a boss giving away a woman's bonus to a man based on his breadwinning status resonated with Hall of Femme attendees.
Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi's Adlyxin
Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal
He is replacing Martin Golden, who was appointed head of global marketing strategy.
BI axes 725 U.S. jobs; Bill Gates supports current U.S. drug pricing; drugmakers are targeting smaller hospitals
Hillary Clinton receives more donations from pharma than republicans; biotech reps have highest salaries; NICE recommends Yervoy-Opdivo combo
According to research conducted in the first quarter, the healthcare products company has a sterling image with millennials despite a series of legal judgments against the company.
Three executives shared some of the challenges women face in the workplace and how they want to shape the next generation of female leaders.
Her hire comes as the insurance giant is merging with Humana in a $37 billion deal.
- BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Wednesday, December 7, 2016
- Five things for pharma marketers to know: Monday, December 5, 2016
- Matt Brown leaves Guidemark Health after merger falls through
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Women in senior industry roles improve connections with patients, execs say